FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2887183730> ?p ?o ?g. }

• W2887183730 abstract "Glioblastoma (GBM) is the most frequent high grade brain tumor in adults. Treatment consists of a combination of maximal surgical resection, radiotherapy and chemotherapy, but prognosis is still poor. Therefore, new therapeutic strategies with other biologically-based therapies is essential to improve the survival of patients with GBM, currently restricted to 15-17 months. This urgent need for better therapies has motivated many studies to pursuit new targets in GBM. Our laboratory demonstrated higher expression of CD99 mRNA in GBM samples when compared to lower grade astrocytomas and non-neoplastic brain tissue. CD99 is a membrane molecule and acts as a key regulator in several biological processes, including cell adhesion, migration, apoptosis, differentiation of T cells and thymocytes, diapedesis of lymphocytes to inflamed vascular endothelium, maintenance of cellular morphology and regulation of intracellular membrane protein trafficking. CD99 expression has been described in many types of cancers, with distinct function and signaling pathways, and its role is not completely elucidated yet, including in GBM.We confirmed the higher CD99 expression in TCGA dataset of GBM cases when compared to grade II and III astrocytomas. Furthermore, amongst GBM cases, Proneural molecular subtype presented lower CD99 expression compared to Mensechymal, Classic and Neural subtypes. We performed functional assays knocking down CD99 with two different shRNAs in the human GBM cell line U87MG. The CD99 silencing efficiency was 80 and 97%, for shRNA_1 and shRNA_2, respectively, confirmed at transcriptional level by quantitative real time PCR and at protein level by Western blot. Significant reduction of migration and invasion of CD99 knocked-down U87MG cells was observed. Additionally, cell shrinkage with relevant reduction of cell area was detected after the silencing of this target, with decreased CD99 localization at lamellipodia by immunocytochemistry. These findings pointed out the cytoskeleton rearrangement with reduction in adhesion sites. Further expression profile analysis after CD99 knockdown by a cancer panel RNAseq confirmed its involvement in cell adhesion, regulation of actin cytoskeleton and ECM-receptor interaction in the KEGG pathways analysis. Interestingly, CD99 knockdown impacted in the reduction of cell adhesion in a distinct quantitative pattern, suggesting that the result is dose dependent. Refinement of this aspect is ongoing in further in vivo assays which will better clarify the CD99 role in tumor cell migration/invasion. Altogether, our results suggest CD99 as a potential new therapeutic target to control GBM infiltrative process, allowing a more efficient treatment outcome. Citation Format: Lais Cavalca Cardoso, Suely Kazue Marie, Roseli Silva Soares, Sueli M. Oba-Shinjo. CD99 expression in astrocytomas and functional analysis in glioblastoma cell line [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2018; 2018 Apr 14-18; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2018;78(13 Suppl):Abstract nr 1075." @default.
• W2887183730 created "2018-08-22" @default.
• W2887183730 creator A5007749348 @default.
• W2887183730 creator A5024584732 @default.
• W2887183730 creator A5028308827 @default.
• W2887183730 creator A5077339049 @default.
• W2887183730 date "2018-07-01" @default.
• W2887183730 modified "2023-09-26" @default.
• W2887183730 title "Abstract 1075: CD99 expression in astrocytomas and functional analysis in glioblastoma cell line" @default.
• W2887183730 doi "https://doi.org/10.1158/1538-7445.am2018-1075" @default.
• W2887183730 hasPublicationYear "2018" @default.
• W2887183730 type Work @default.
• W2887183730 sameAs 2887183730 @default.
• W2887183730 citedByCount "0" @default.
• W2887183730 crossrefType "proceedings-article" @default.
• W2887183730 hasAuthorship W2887183730A5007749348 @default.
• W2887183730 hasAuthorship W2887183730A5024584732 @default.
• W2887183730 hasAuthorship W2887183730A5028308827 @default.
• W2887183730 hasAuthorship W2887183730A5077339049 @default.
• W2887183730 hasBestOaLocation W28871837301 @default.
• W2887183730 hasConcept C104317684 @default.
• W2887183730 hasConcept C119056186 @default.
• W2887183730 hasConcept C126226738 @default.
• W2887183730 hasConcept C142724271 @default.
• W2887183730 hasConcept C147447768 @default.
• W2887183730 hasConcept C1491633281 @default.
• W2887183730 hasConcept C173396325 @default.
• W2887183730 hasConcept C190232843 @default.
• W2887183730 hasConcept C203014093 @default.
• W2887183730 hasConcept C204232928 @default.
• W2887183730 hasConcept C2778227246 @default.
• W2887183730 hasConcept C502942594 @default.
• W2887183730 hasConcept C54355233 @default.
• W2887183730 hasConcept C55493867 @default.
• W2887183730 hasConcept C62112901 @default.
• W2887183730 hasConcept C71924100 @default.
• W2887183730 hasConcept C81885089 @default.
• W2887183730 hasConcept C86803240 @default.
• W2887183730 hasConceptScore W2887183730C104317684 @default.
• W2887183730 hasConceptScore W2887183730C119056186 @default.
• W2887183730 hasConceptScore W2887183730C126226738 @default.
• W2887183730 hasConceptScore W2887183730C142724271 @default.
• W2887183730 hasConceptScore W2887183730C147447768 @default.
• W2887183730 hasConceptScore W2887183730C1491633281 @default.
• W2887183730 hasConceptScore W2887183730C173396325 @default.
• W2887183730 hasConceptScore W2887183730C190232843 @default.
• W2887183730 hasConceptScore W2887183730C203014093 @default.
• W2887183730 hasConceptScore W2887183730C204232928 @default.
• W2887183730 hasConceptScore W2887183730C2778227246 @default.
• W2887183730 hasConceptScore W2887183730C502942594 @default.
• W2887183730 hasConceptScore W2887183730C54355233 @default.
• W2887183730 hasConceptScore W2887183730C55493867 @default.
• W2887183730 hasConceptScore W2887183730C62112901 @default.
• W2887183730 hasConceptScore W2887183730C71924100 @default.
• W2887183730 hasConceptScore W2887183730C81885089 @default.
• W2887183730 hasConceptScore W2887183730C86803240 @default.
• W2887183730 hasLocation W28871837301 @default.
• W2887183730 hasOpenAccess W2887183730 @default.
• W2887183730 hasPrimaryLocation W28871837301 @default.
• W2887183730 hasRelatedWork W1982196169 @default.
• W2887183730 hasRelatedWork W2039201715 @default.
• W2887183730 hasRelatedWork W2052359587 @default.
• W2887183730 hasRelatedWork W2059207205 @default.
• W2887183730 hasRelatedWork W2363215599 @default.
• W2887183730 hasRelatedWork W2373150114 @default.
• W2887183730 hasRelatedWork W2995726900 @default.
• W2887183730 hasRelatedWork W3186442177 @default.
• W2887183730 hasRelatedWork W4224921457 @default.
• W2887183730 hasRelatedWork W2574957698 @default.
• W2887183730 isParatext "false" @default.
• W2887183730 isRetracted "false" @default.
• W2887183730 magId "2887183730" @default.
• W2887183730 workType "article" @default.